Showing results (101-110 of 172) with videos related to
Sort By:
Pageof 18
The Lancet. Healthy Longevity|July 11, 2022
Duration of vaccine effectiveness against SARS-CoV-2 infection, hospitalisation, and death in residents and staff of long-term care facilities in England (VIVALDI): a prospective cohort studyMadhumita Shrotri, Maria Krutikov, Hadjer Nacer-Laidi, et al.European Journal of Immunology|September 26, 2017
NK cells produce high levels of IL-10 early after allogeneic stem cell transplantation and suppress development of acute GVHDYuen Ling Tracey Chan, Jianmin Zuo, Charlotte Inman, et al.Blood|November 14, 2015
ATR inhibition induces synthetic lethality and overcomes chemoresistance in TP53- or ATM-defective chronic lymphocytic leukemia cellsMarwan Kwok, Nicholas Davies, Angelo Agathanggelou, et al.Oncotarget|May 13, 2017
Dynamic changes in clonal cytogenetic architecture during progression of chronic lymphocytic leukemia in patients and patient-derived murine xenograftsNicholas J Davies, Marwan Kwok, Clive Gould, et al.Blood|October 29, 2015
TALEN-mediated genetic inactivation of the glucocorticoid receptor in cytomegalovirus-specific T cellsLaurie Menger, Agnes Gouble, Maria A V Marzolini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 24, 2012
Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trialAnna Skowronska, Anton Parker, Gulshanara Ahmed, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 7, 2022
Serological responses to COVID-19 Comirnaty booster vaccine, London, United Kingdom, September to December 2021Georgina Ireland, Heather Whitaker, Shamez N Ladhani, et al.Frontiers in Immunology|January 11, 2020
Long-Term Ibrutinib Therapy Reverses CD8<sup>+</sup> T Cell Exhaustion in B Cell Chronic Lymphocytic LeukaemiaHelen M Parry, Nikhil Mirajkar, Natasha Cutmore, et al.The Lancet. Healthy Longevity|December 22, 2021
Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in EnglandMaria Krutikov, Tom Palmer, Gokhan Tut, et al.The Lancet. Infectious Diseases|June 26, 2021
Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort studyMadhumita Shrotri, Maria Krutikov, Tom Palmer, et al.Pageof 18